Hope in sight TM

Our research is bringing hope to people affected by vision loss and blindness

Donate Now

Help us provide hope to people living with AMD

Your gift will help research into age‑related macular degeneration, giving hope for a brighter world for those living with AMD-related vision loss.


Find out more about how glaucoma researchers at CERA are leading the way towards new treatments in the recording of our World Glaucoma Day Community Forum.

Eye Conditions

Our Understanding age-related macular degeneration guide gives you an introduction to the disease and CERA's world-class research.


Explore research projects currently open for expressions of interest from Masters, Doctorate or PhD students.

Celebrating Cerulea Clinical Trials

Cerulea Clinical Trials, CERA’s new not-for-profit clinical trials centre, is up and running.
Learn how Cerulea will transform the delivery of ophthalmic clinical trials, increase community access to sight-saving therapies and deliver excellence for clinicians, trial participants and sponsors.

Read more

Take part in research

Help shape the future of vision research by taking part in a clinical study.
Find out how you can take part in studies at CERA and Cerulea Clinical Trials for eye conditions including age-related macular degeneration, corneal conditions, diabetic retinopathy, glaucoma and inherited retinal disease.

Learn more

Latest News


21 May 2024

Cerulea Clinical Trials, launched today in Melbourne, will bring more international trials to Victoria and give people living with vision loss and blindness early access to sight-saving therapies.


09 May 2024

Thanks to tireless research, it’s hoped people will be diagnosed with ‘dry’ age-related macular degeneration earlier and have clear pathways to treatments.


09 May 2024

A new project is using cutting-edge DNA sequencing technology to find the genetic cause of not-yet-understood inherited retinal diseases.


09 May 2024

On International Nurses Day, we celebrate our Lions Eye Donation Service coordinators out in the field and in the lab – working to protect sight for current and future generations.

Eye-news emails are sent to subscribers once a month

Newsletter Subscribe
Receive Appeals